Office, Home, and Ambulatory Blood Pressure

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-19
SponsorChildren's Hospital Medical Center, Cincinnati

About this trial

This will be a prospective observational study. The population would be pediatric patients 6 years to \<19 years of age who were referred for elevated blood pressure to investigate if home blood pressure (HBP) can determine blood pressure phenotype (normotensive, hypertensive, masked hypertension, white coat hypertension) as accurately as ambulatory blood pressure monitor (ABPM) in childhood and adolescence.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 6 years to <19 years old;

Elevated blood pressure defined as 15% lower than the 95%ile BP based on clinical practice guidelines(CPG) but less than stage II hypertension based on CPG;

Tolerate ABPM 24 hours;

Tolerate HBP; and

Disqualifiers

On antihypertension medications or treated in the last 6 months;

Pregnant;

Obstructive valvular disease

Coarctation of the aorta

Trial population

The population will be pediatric patients 6 years to \<19 years years of age who were referred for elevated blood pressure to the Recruitment Hypertension clinic, Lipid Clinic, or Center for Better Health and Nutrition.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

52 Participants
are grouped into 1 trial group
Group A: All Participants

Trial outcomes

Primary outcomes

1

Determine blood pressure phenotype

The primary objective of this study is to investigate if home blood pressure (HBP) can determine blood pressure phenotype (normotensive, hypertensive, masked hypertension, white coat hypertension) as accurately as ambulatory blood pressure monitor (ABPM) in childhood and adolescence.

Time frame
6-12 months after enrollment

Secondary outcomes

1

HBP correlation with end organ damage

Our secondary objective is to determine if HBP correlates with end organ damage (i.e. elevated left ventricular mass, increased arterial stiffness, and decreased left ventricular strain) better than office BP. Our central hypothesis is that home blood pressure will accurately identify blood pressure phenotype and will correlate with end organ damage.

Time frame
6-12 months after enrollment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.